Lonza Group, CH0013841017

CLSA raised target for Lonza Group stock from CHF 759 to CHF 778

Published on 10/27/2026 at 10:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza targets 10.00-13.00 percent organic growth. Lonza Group stock costs EUR 684.60 on October 27, 2026 versus the Xetra close of October 26, 2026.

Targets and trading context

  • CLSA raised Lonza's target from CHF 759 to CHF 778 on October 16, 2026.
  • Lonza targets 10.00-13.00 percent organic growth over the medium term.
  • Lonza Group stock trades at EUR 684.60 at 10:06 a.m. CET at Lang & Schwarz on October 27, 2026, 0.12 percent above the Xetra close of October 26, 2026.
  • Lonza scheduled its full-year 2026 results for January 27, 2027.
Lonza Group, CH0013841017, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) was trading at EUR 684.60 at Lang & Schwarz on October 27, 2026 at 10:06 a.m. CET. The latest analyst action came from CLSA, which raised its target from CHF 759 to CHF 778 on October 16, 2026, according to Boerse Express.

Three milestones reshape the outlook

Lonza reported sales of CHF 3.4 billion and constant-exchange-rate sales growth of 16.00 percent for the first half of 2026, as described in the Yahoo Finance transcript dated July 22, 2026. On October 14, 2026, the company set a medium-term organic growth model of 10.00-13.00 percent and a high-thirties CORE EBITDA margin through its official update.

What do the targets mean?

The near-term framework remains narrower: Lonza reaffirmed 2026 constant-exchange-rate sales growth of 11.00-12.00 percent and a CORE EBITDA margin of 33.00-34.00 percent in its Lonza release. That separates the current-year forecast from the longer-term ambition. The company also expects the planned sale of Capsules and Health Ingredients to close before the end of 2026, leaving execution and capital allocation as important markers.

Chronology shows a widening ambition

On July 22, 2026, Lonza reported CHF 3.4 billion in first-half sales and 16.00 percent constant-exchange-rate growth, according to Yahoo Finance. On October 14, 2026, it reaffirmed 11.00-12.00 percent 2026 sales growth and a 33.00-34.00 percent CORE EBITDA margin. On October 16, 2026, CLSA lifted its target from CHF 759 to CHF 778, as reported by Boerse Express.

Upcoming dates set the next test

Lonza's next explicitly scheduled financial milestone is its full-year 2026 results on January 27, 2027. The company's agenda also lists a Berenberg virtual event on November 26, 2026, according to its Lonza calendar.

Stock holds above the Xetra close

Lonza Group stock was 0.12 percent above the Xetra close of October 26, 2026, which was EUR 683.80. At Lang & Schwarz, the stock was trading at EUR 684.60 on October 27, 2026 at 10:06 a.m. CET, an intraday price during the Xetra trading phase. The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.

Lonza Group stock facts

  • Company: Lonza Group AG
  • ISIN: CH0013841017
  • Ticker: LONN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz as of October 27, 2026, 10:06 a.m. CET: EUR 684.60
  • Change versus Xetra close: plus 0.12 percent
  • Xetra close October 26, 2026: EUR 683.80
  • Sector / Industry: Healthcare / contract drug manufacturing

Market context: Market report SMI.

More news and analyses on Lonza Group stock

Disclaimer...
en | CH0013841017 | LONZA GROUP | boerse | 70418856 |